LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Impact of the disclosure of diagnosis on posttraumatic stress and growth and quality of life in Chinese patients with hepatocellular carcinoma

Photo from wikipedia

Purpose To evaluate the impact of disclosure/nondisclosure of cancer diagnosis on patients’ posttraumatic stress symptoms (PTSS), posttraumatic growth (PTG), and quality of life (QOL). Methods Patients with primary hepatocellular carcinoma… Click to show full abstract

Purpose To evaluate the impact of disclosure/nondisclosure of cancer diagnosis on patients’ posttraumatic stress symptoms (PTSS), posttraumatic growth (PTG), and quality of life (QOL). Methods Patients with primary hepatocellular carcinoma (HCC) who were admitted for potentially curative treatments in a teaching hospital were recruited. Patients were interviewed at admission regarding their QOL and their attitude towards disclosure of diagnosis. They were interviewed again for QOL, PTSS, and PTG at discharge and at 1 month after discharge. Results There were 300 patients recruited, 88.3% of whom preferred disclosure of cancer diagnosis. In fact, 162 patients (54.0%) received disclosure of their cancer diagnosis before discharge (disclosed group). However, for the 138 patients whose diagnoses were concealed by their families (uninformed group), 116 patients (84.1%) had learned of their diagnosis of HCC independently within 1 month after discharge. Comparing the scores at 1 month after discharge with scores at discharge showed that the PTSS score significantly declined for patients in the disclosed group and the PTG score significantly decreased for the uninformed patients at 1 month after discharge ( p  < 0.001 for both comparisons). Additionally, compared with the uninformed group, patients in the disclosed group had lower scores for PTSS ( p  < 0.001), higher scores for PTG ( p  < 0.001), better emotional functioning ( p  < 0.001), and better global QOL ( p  = 0.006) at 1 month after discharge. Conclusions Our findings indicate that concealing the diagnosis of cancer from patients is unlikely to succeed. Additionally, disclosure of diagnosis is beneficial for HCC patients in reducing PTSS and improving PTG and QOL.

Keywords: diagnosis; month discharge; disclosure; disclosure diagnosis; cancer

Journal Title: Supportive Care in Cancer
Year Published: 2019

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.